Koichi Suzuki

Title: Innovations by Koichi Suzuki in Allergy Prediction

Introduction

Koichi Suzuki is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of allergy prediction through his innovative methods. His work focuses on understanding and predicting the risk of developing allergies in infants, which is crucial for early intervention and management.

Latest Patents

Koichi Suzuki holds a patent for a method that collects data to predict the risk of developing allergies. This patent, titled "Method for collecting data to predict risk of developing allergies," outlines a means for predicting an infant's risk of developing an allergy to an allergen. The process involves measuring IgG1 and IgE antibody titers against egg white in samples from infants aged six months or younger using a DCP chip. A scattergram is created by plotting the IgG1 antibody titer on the X-axis and the IgE antibody titer on the Y-axis. The data distribution is divided into two blocks, and a linear function applicable to each block is calculated. This allows for the prediction of an infant's risk of developing an allergy based on the block to which they belong.

Career Highlights

Koichi Suzuki is associated with the Applied Medical Enzyme Research Institute Corporation, where he continues to advance research in medical applications. His innovative approach to allergy prediction has the potential to significantly impact pediatric healthcare.

Collaborations

Some of his notable coworkers include Hiroshi Kido and Makoto Irahara, who contribute to the collaborative efforts in research and development within the institute.

Conclusion

Koichi Suzuki's work in predicting allergies represents a significant advancement in medical research. His innovative methods provide valuable insights that can lead to better health outcomes for infants at risk of allergies.